ReviewSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2026
[Research progress on the acquisition technology of magnetocardiography].
Review in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For certain cardiovascular diseases such as coronary artery disease and arrhythmia, electrocardiogram as a conventional cardiac function monitoring method has limitations such as insufficient resolution and unreliable accuracy in diagnosis. In contrast, magnetocardiography (MCG) offers several advantages, such as being unaffected by uneven human body conductivity and skin-electrode contact, and providing higher spatial resolution, which make it more effective than electrocardiogram for pathological characterization and lesion localization. The acquisition technology of MCG, which is a vital component of the overall MCG system, has predominantly utilized superconducting quantum interference device. In recent years innovative cases of MCG acquisition using atomic magnetometers and magneto-resistive sensors have also appeared in academia. In this paper, the MCG acquisition technologies based on three distinct magnetic sensors are reviewed. Firstly, the current research progress on each MCG acquisition technology is introduced. After that, the enhancement approaches of various technologies for improving cardiac magnetic signal acquisition and magnetic shielding conditions are discussed. Subsequently, differences between each technology are analyzed and the existing development difficulties and solutions of MCG technology are discussed. Finally, an outlook on the application prospect of MCG in the clinical field is provided, aiming to provide references for the continuous optimization of MCG technology and accelerate its adoption as a reliable diagnostic method for cardiovascular diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.